Clinical trial
A Long-term Trial of OPC-34712 in Patients With Schizophrenia
NCT01456897 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Trial of OPC-34712 in Patients With Schizophrenia
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- Not reported
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.